HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Tami Livnat Selected Research
Tami Livnat Research Topics
Disease
24
Hemorrhage
01/2022 - 01/2006
16
Hemophilia A (Haemophilia)
01/2022 - 09/2009
8
Choroidal Neovascularization
01/2021 - 12/2010
4
Hemophilia B (Haemophilia B)
01/2020 - 01/2017
4
Inflammation (Inflammations)
12/2019 - 01/2015
4
Corneal Neovascularization
01/2019 - 01/2016
4
Thrombasthenia (Glanzmann Thrombasthenia)
01/2019 - 01/2012
4
Thrombosis (Thrombus)
12/2018 - 09/2009
3
Retinal Detachment (Retinal Detachments)
12/2019 - 01/2017
3
Hypoxia (Hypoxemia)
02/2019 - 12/2010
3
Chemical Burns (Chemical Burn)
01/2019 - 01/2016
3
Thrombocytopenia (Thrombopenia)
12/2018 - 12/2009
3
Factor XI Deficiency (Hemophilia C)
08/2015 - 06/2003
2
von Willebrand Diseases (von Willebrand's Disease)
01/2022 - 01/2021
2
Metrorrhagia (Spotting)
09/2021 - 01/2020
2
Hemarthrosis
01/2021 - 01/2017
2
Diabetic Retinopathy (Retinopathy, Diabetic)
12/2019 - 01/2017
2
Rupture
11/2017 - 01/2016
2
Myopia
04/2016 - 10/2014
2
Alzheimer Disease (Alzheimer's Disease)
01/2016 - 01/2015
1
Joint Diseases (Joint Disease)
01/2021
1
Type 3 von Willebrand Disease
01/2021
1
Wounds and Injuries (Trauma)
10/2020
1
Anaphylaxis (Anaphylactic Shock)
01/2020
1
Hypersensitivity (Allergy)
12/2018
1
Neonatal Alloimmune Thrombocytopenia
12/2018
1
Retinal Perforations
01/2018
1
Mycosis Fungoides
10/2017
1
Multiple Myeloma
01/2017
1
Retinal Diseases
01/2017
1
Pathologic Neovascularization
01/2016
1
Ocular Hypertension (Glaucoma, Suspect)
01/2016
1
Degenerative Myopia
10/2014
Drug/Important Bio-Agent (IBA)
11
Thrombin
FDA Link
01/2022 - 09/2009
7
emicizumab
IBA
09/2021 - 11/2019
6
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2021 - 12/2010
5
recombinant FVIIa (rFVIIa)
FDA Link
01/2020 - 09/2009
4
Fibrinogen (Factor I)
FDA Link
01/2022 - 01/2012
4
Proteins (Proteins, Gene)
FDA Link
12/2019 - 01/2011
4
Retinaldehyde (Retinal)
IBA
02/2019 - 09/2007
4
Antibodies
IBA
12/2018 - 12/2009
3
Factor VIII (Coagulation Factor VIII)
IBA
08/2021 - 09/2018
3
Blood Coagulation Factors (Coagulation Factor)
IBA
01/2020 - 12/2009
3
Factor VIIa (Activated Factor VII)
IBA
01/2020 - 09/2009
3
aflibercept
IBA
01/2019 - 01/2016
3
Retinal Pigments (Pigments, Visual)
IBA
01/2016 - 12/2010
2
Hemostatics (Antihemorrhagics)
IBA
01/2022 - 01/2017
2
Factor VII (Proconvertin)
IBA
05/2021 - 07/2012
2
Protein C
IBA
01/2021 - 01/2019
2
Prothrombin (Factor II)
IBA
01/2020 - 01/2017
2
Histone Deacetylase Inhibitors
IBA
02/2019 - 07/2017
2
Factor IX (Coagulation Factor IX)
FDA Link
Generic
12/2018 - 09/2018
2
anti-inhibitor coagulant complex
IBA
01/2018 - 01/2017
2
Autoantibodies
IBA
03/2017 - 12/2009
2
Bevacizumab (Avastin)
FDA Link
07/2016 - 01/2016
2
Riboflavin (Vitamin B2)
FDA Link
Generic
04/2016 - 10/2014
2
Apolipoprotein E4
IBA
01/2016 - 01/2015
2
Factor XIII (Coagulation Factor XIII)
IBA
01/2014 - 01/2012
2
hypericin
IBA
01/2011 - 09/2007
2
Factor XI (Plasma Thromboplastin Antecedent)
IBA
01/2006 - 06/2003
1
marstacimab
IBA
01/2022
1
Vitamin K
FDA Link
01/2022
1
lipoprotein-associated coagulation inhibitor (TFPI)
IBA
01/2022
1
A-factor (Streptomyces)
IBA
09/2021
1
Anticoagulants
IBA
01/2021
1
Antithrombins
IBA
01/2020
1
Factor IXa (Coagulation Factor IXa)
IBA
11/2019
1
Factor X (Stuart Factor)
IBA
11/2019
1
Betamethasone (Celestone)
FDA Link
01/2019
1
Eosine Yellowish-(YS) (Eosin)
IBA
01/2019
1
Hematoxylin (Haematoxylon)
IBA
01/2019
1
Endothelial Growth Factors
IBA
01/2019
1
Integrins
IBA
12/2018
1
Intravenous Immunoglobulins (IVIG)
FDA Link
12/2018
1
prothrombin complex concentrates (PPSB)
IBA
12/2018
1
Hydrogels
IBA
01/2018
1
Biomarkers (Surrogate Marker)
IBA
10/2017
1
diethoxyphosphoryloxymethyl butanoate
IBA
07/2017
1
Rituximab (Mabthera)
FDA Link
03/2017
1
Solutions
IBA
01/2017
1
Salts
IBA
01/2017
1
antithrombin III-protease complex
IBA
01/2017
1
Immunomodulating Agents
IBA
01/2017
1
Interleukin-6 (Interleukin 6)
IBA
01/2017
1
Cytokines
IBA
01/2017
1
Tellurium
IBA
01/2016
1
Interleukin-8 (Interleukin 8)
IBA
01/2016
1
Apolipoprotein E3
IBA
01/2015
1
Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)
IBA
01/2014
1
Thromboplastin (Tissue Factor)
IBA
01/2014
Therapy/Procedure
13
Therapeutics
01/2022 - 01/2011
3
Minor Surgical Procedures (Minor Surgery)
11/2019 - 01/2017
3
Platelet Transfusion (Blood Platelet Transfusions)
01/2019 - 01/2018
1
Vitrectomy
12/2019
1
Aftercare (After-Treatment)
01/2019
1
Operative Surgical Procedures
09/2018
1
Lasers (Laser)
11/2017
1
Immunomodulation
03/2017
1
Light Coagulation
01/2016
1
Semiconductor Lasers
01/2016